目前对瘤学的理解状况在马来西亚扩大了访问计划的范围
The Medical journal of Malaysia
|March 30, 2024
概括
扩展准入计划 (EAP) 为具有有限选择的患者提供关键的研究药物准入. 虽然马来西亚的瘤学家有相当的了解,但需要进一步的培训来增加EAP的使用率.
科学领域:
- 在瘤学瘤学.
- 临床药理学 临床药理学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 扩展获取计划 (EAP) 是研究药物的监管途径.
- EAP为患有危及生命的患者提供服务,这些患者已经耗尽了标准治疗方法.
- 当参与临床试验不是一种选择时,这些计划至关重要.
研究的目的:
- 评估马来西亚瘤学家对EAP的知识和理解.
- 确定马来西亚EAP利用的障碍和促进因素.
主要方法:
- 对马来西亚的瘤学家进行了一项匿名,在线,自愿的调查.
- 该调查于2020年4月至6月期间进行.
- 参与者是瘤学家,他们以前询问过EAPs.
主要成果:
- 15名瘤学家参与,其中80%在前一年提交了1-10份EAP申请.
- 73.3%的受访者表示,缺乏对EAP的机构资源或培训.
- 53%的人认为他们对EAP和申请流程的了解"很好",而73.3%的人希望学习教育模块.
结论:
- 马来西亚的瘤学家对EAP及其应用流程有相当的了解.
- 需要加强培训和意识,以改善EAP的利用.
- 制药公司应在其网站上提供易于访问的EAP信息.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.1K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Nursing Ethical Principles II
958
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
958
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
